On the third day of the MEDICA exhibition, the pace became more focused, with deep engagements taking center stage. Professionals from all over the world gathered at the WBL booth, engaging in intensive discussions about the clinical applications, market implementation, and cooperation details of LIPUS micro-energy medical technology. The depth and specificity of consultations were significantly elevated, with the convergence of three core forces—cultural, clinical, and commercial—creating a clearer market profile for male healthcare and highlighting WBL's global appeal.

Focused Engagement: Deep Consultations Outline a Clear Market Profile

On the third day of the exhibition, the focus shifted to addressing core needs, with the quality of consultations undergoing a complete upgrade. Visitors were no longer satisfied with surface-level information but instead engaged in long, in-depth discussions with clear objectives, turning market demands from vague concepts into concrete realities.

1.Potential partners went straight to the point, discussing the “technology introduction process” and cooperation details.

2.Representatives from medical institutions focused on “clinical evaluation standards” to verify the technology's suitability.

3.Physicians came with “clinical pain points,” urgently seeking targeted solutions.

Each deep dialogue lasting over 20 minutes contributed to refining WBL’s global strategy and filling in precise market dimensions.

Middle Eastern Market: Urgent Demand, Focusing on Core Clinical Implementation

The demand characteristics of the Middle Eastern market stood out during the deep consultations on the third day. Local clients and physicians' inquiries were direct and focused, revolving entirely around “clinical effectiveness” and “feasibility,” with no unnecessary discussions:

“Can the technology truly improve male function?”

“How is the clinical data supported?”

“How long does a complete treatment course take to show results?”

“What are the adaptation plans for different symptoms?”

“How quickly can physician training be completed?”

“When can local clinical applications be initiated?”

These focused inquiries stemmed from the deep cultural ties between male identity, capability, and family responsibility in the Middle East. The local market displayed an uncommon level of attention toward non-invasive treatments that are “painless, have no side effects, and are reversible,” and WBL’s LIPUS technology perfectly aligns with these core demands, making it a “targeted focus” for many clients.

Empowering Physicians: Deep Consultations Decode Core Logic of the Middle Eastern Market

A deep conversation between an Iranian client and Turkish urology authority Dr. Alp revealed the core logic of the Middle Eastern market. Dr. Alp's presence became the driving engine for deep consultations. The Iranian client directly stated that the endorsement of key physicians serves as a market barometer, and their academic sharing could lead to precise demand. VIP clients reject pain and only seek true functional recovery. This statement became a consensus among Middle Eastern clients on the day—physician authority is the key to implementing technology, with repeated verification of clinical endorsements during consultations; the high-end market's urgent needs are focused on functional recovery, not superficial stimulation, with detailed inquiries into clinical evidence and case details; and they deeply understood the essential differences between LIPUS repair and Shockwave stimulation, proactively exploring the appropriate scenarios.

Under Dr. Alp's professional guidance, client consultations shifted from questions about product parameters and operating modes to more in-depth clinical issues: discussing treatment logic and patient adaptation standards, inquiring about treatment cycles and follow-up methods, verifying vascular regeneration and nerve repair mechanisms, and consulting on scenario-based operational decision points. This shift confirmed the Middle Eastern market's core demand: it’s not about new devices but mature technologies that deliver clear clinical results, and the physician's professional interpretation turned LIPUS from an equipment upgrade into a reliable treatment solution, pushing consultations toward actual cooperation.

Mature Markets Fill the Gaps, Deep Consultations Cover Global Dimensions

Another highlight of the third day was the appearance of clients from mature markets, who had been less visible on the previous days. These clients brought high-level, deep consultations, completing key pieces of the puzzle for WBL’s global market strategy.French clients focused on clinical trial protocols and evidence-based medical research, discussing the feasibility of multi-center study cooperation.German clients delved into the treatment standardization process and indications segmentation, with a strong emphasis on medical system compatibility.Korean clients had high professional demands, consulting on precise technical advantages and local market needs.Belarusian clients inquired about treatment scenarios and application boundaries, systematically assessing the feasibility of regional implementation.These high-level consultations propelled WBL’s international market strategy from regional breakthroughs to full global coverage.

Three Core Directions Formed: Deep Consultations Shape the Global Market Blueprint

After three days of exhibition, particularly the deep consultation surge on the third day, WBL’s global map for male healthcare took shape around three core directions:The Middle Eastern market, driven by cultural factors and urgent needs, focuses on quick implementation, physician endorsement, and clinical effectiveness. It is the key region for short-term cooperation.The European and Korean markets are clinical-standard-driven brand leaders, focusing on multi-center evidence, standardized processes, and academic education. They are key battlegrounds for building global brand influence.Cross-national physician exchanges have become the core link for technology dissemination. Physicians from different countries engaged in deep discussions around treatment logic, making WBL LIPUS a universally understood medical language, laying a solid foundation for the global spread of the technology.

Deep Focus Marks the Official Launch of WBL's International Strategy

The third day of MEDICA concluded with core collaborations solidified, the global strategy refined, and technology value and market positioning clarified, marking the exhibition’s qualitative closure. The conclusion of the exhibition is by no means the end but rather a new starting point for WBL’s international strategy. Moving forward, based on the outcomes of deep consultations, WBL will advance regional cooperation, multi-center clinical studies, and the establishment of a global agent network, bringing LIPUS technology to patients worldwide.